RASSF1 and carcinoma: For three genes reported in at least three studies between HBV-positive carcinoma serums and HBV-negative carcinoma serums (Table 3), no evidence of statistical heterogeneity was observed for two genes, including RASSF1A (I2 = 0%) and APC (I2 = 0%).